| 英文名称 | 中文名称 | CAS | MF |
|
N-DBCO-N-bis(PEG2-NHS ester)
|
N-DBCO-N-bis(PEG2-NHS ester)
|
2128735-29-3
|
C41H46N4O14
|
|
(5AR,10bS)-2-mesityl-9-nitro-5a,10b-dihydro-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazin-2-ium tetrafluoroborate
|
(5AR,10BS)-2-均三甲苯基-9-硝基-5A,10B-二氢-4H,6H-茚并[2,1-B][1,2,4]三唑并[4,3-D][1,4]恶嗪-2-鎓四氟硼酸盐
|
2128740-77-0
|
C21H21BF4N4O3
|
|
Methanesulfonato (di-tert-butyl) methylphosphino (2′-amino-1,1′-biphenyl-2-yl) palladium(II)
|
Methanesulfonato (di-tert-butyl) methylphosphino (2′-amino-1,1′-biphenyl-2-yl) palladium(II)
|
2128748-50-3
|
C22H34NO3PPdS
|
|
9,9-diphenyl- 9H-fluoren-2-ol
|
2-羟基-9,9-二苯基芴
|
2129175-85-3
|
C25H18O
|
|
Sulfo-Cy5-TCO
|
水溶性CY5-反式环辛烯
|
2129525-69-3
|
C46H62N4O12S3
|
|
6-Isoquinolinecarboxylic acid, 2-(6-benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-
|
6-Isoquinolinecarboxylic acid, 2-(6-benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-
|
2129597-34-6
|
C19H13Cl2NO4
|
|
4,4-bis(4-hexylphenyl)-6-(thiophen-2-yl)-4H-indeno[1,2-b]thiophene
|
PM271
|
2129627-54-7
|
C39H42S2
|
|
Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 8,9,10,11,12,13,14,15-octahydro-4-hydroxy-2,6-bis(4-nitrophenyl)-, 4-oxide, (11bS)-
|
(11bS)-4-羟基-2,6-双(4-硝基苯基)-8,9,10,11,12,13,14,15-八氢二萘并[2,1-d:1',2'-f ][1,3,2]二氧膦杂环庚三烯 4-氧化物
|
2129645-31-2
|
C32H27N2O8P
|
|
[1,1'-Binaphthalene]-2,2'-diol, 5,5',6,6',7,7',8,8'-octahydro-3,3'-bis(4-nitrophenyl)-, (1S)-
|
(S)-3,3-双(4-硝基苯基)-1,1-5,5',6,6',7,7',8,8'-八氢联萘酚
|
2129645-35-6
|
C32H28N2O6
|
|
3-Azabicyclo[3.1.0]hexane-3-carboxylic acid, 6,6-difluoro-, 1,1-dimethylethyl ester
|
6,6-二氟-3-氮杂双环[3.1.0]己烷-3-羧酸叔丁酯
|
2129647-30-7
|
C10H15F2NO2
|
|
tert-butyl 1,1-difluoro-5-azaspiro[2.3]hexane-5-carboxylate
|
1,1-二氟-5-氮杂螺[2.3]-5-羧酸叔丁酯
|
2129647-31-8
|
C10H15F2NO2
|
|
1,4-Benzenedicarboxylic acid, 2,5-dichloro-3-(2,4,5,7-tetrachloro-6-hydroxy-3-oxo-3H-xanthen-9-yl)-, 1-(2,5-dioxo-1-pyrrolidinyl) ester
|
1,4-Benzenedicarboxylic acid, 2,5-dichloro-3-(2,4,5,7-tetrachloro-6-hydroxy-3-oxo-3H-xanthen-9-yl)-, 1-(2,5-dioxo-1-pyrrolidinyl) ester
|
2129651-79-0
|
C25H9Cl6NO9
|
|
PHY34
|
化合物PHY34
|
2130033-55-3
|
C30H30O12
|
|
Benzo[b]naphtho[1,2-d]furan, 2-(4-chlorophenyl)-
|
|
2130048-87-0
|
C22H13ClO
|
|
Exemestane EP Impurity C
|
依西美坦EP杂质C
|
2130745-60-5
|
C21H24O2
|
|
4',4''',4'''''-(1,3,5-triazine-2,4,6-triyl)tris(([1,1'-biphenyl]-4-amine))
|
4',4''',4'''''-(1,3,5-triazine-2,4,6-triyl)tris(([1,1'-biphenyl]-4-amine))
|
2130745-76-3
|
C39H30N6
|
|
Benzaldehyde, 4-(phenylmethoxy)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
|
4-(苄氧基)-2-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)苯甲醛
|
2130752-37-1
|
C20H23BO4
|
|
6-(tert-Butylthio)benzo[c][1,2]oxaborol-1(3H)-ol
|
|
2130753-07-8
|
C11H15BO2S
|
|
Levofloxacin-007-S
|
左氧氟沙星标准品7-S
|
2130840-90-1
|
C20H25FN4O4
|
|
Nintedanib Impurity 93
|
Nintedanib Impurity 93
|
2130844-77-6
|
C33H35N5O5
|
|
Mal-PEG2-VCP-Eribulin
|
Mal-PEG2-VCP-Eribulin
|
2130869-18-8
|
C70H99N7O21
|
|
5-Chloro-6-(morpholino)pyridine-3-boronic acid
|
5-氯-6-吗啉吡啶-3-硼酸
|
2130896-19-2
|
C9H12BClN2O3
|
|
N-H-IndoleBX
|
N-H-IndoleBX
|
2130906-05-5
|
C15H10INO2
|
|
L-Lysine, L-lysyl-L-tyrosyl-L-lysyl-L-glutaminyl-L-lysyl-L-arginyl-L-arginyl-L-seryl-L-tyrosyl-
|
HCPNE7蛋白肽
|
2130912-34-2
|
C62H105N21O15
|
|
AST2818 mesylate
|
甲磺酸伏美替尼
|
2130958-55-1
|
C29H35F3N8O5S
|
|
2DPP-2CNTVT
|
PFT-100, PATENTED BY 1M; OS0474-NEW
|
2130979-39-2
|
|
|
GLPG2938
|
GLPG2938
|
2130996-00-6
|
C20H19F6N7O2
|
|
4-Amino-5-ethynyl-2-fluorobenzonitrile
|
4-氨基-5-乙炔基-2-氟苯腈
|
2131007-03-7
|
C9H5FN2
|
|
4-Chloro-2,9-dimethyl-1,10-phenanthroline
|
4-氯-2,9-二甲基-1,10-菲咯啉
|
2131054-09-4
|
C14H11ClN2
|
|
2,1,3-Benzothiadiazole-4-carboxaldehyde, 7-[4-[bis(4-methoxyphenyl)amino]phenyl]-
|
7-(4-(双(4-甲氧基苯基)胺)苯并)苯并[C][1,2,5]噻二唑-4-醛基
|
2131058-21-2
|
C27H21N3O3S
|
|
(S)-(2-methoxyphenyl)((tetrahydro-2H-pyran-4-yl)oxy)methanol
|
CPD5077-G-A4-S
|
2131091-23-9
|
C14H20O4
|
|
(R)-2-(2-methoxyphenyl)-2-((tetrahydro-2H-pyran-4-yl)oxy)ethyl methanesulfonate
|
ND-630中间体,CPD1701
|
2131091-26-2
|
C15H22O6S
|
|
tert-butyl 2-methyl-2-(5-methyl-6-(oxazol-2-yl)-2,4-dioxo-1,2-dihydrothieno[2,3-d]pyrimidin-3(4H)-yl)propanoate
|
叔丁基2-甲基-2-[5-甲基-6-(1,3-恶唑-2-基)-2,4-二氧-1H-噻吩并[2,3-d]嘧啶-3-基]丙酸酯
|
2131091-31-9
|
C18H21N3O5S
|
|
4',4'''-(2,2-diphenylethene-1,1-diyl)bis([1,1'-biphenyl]-4-carbaldehyde)
|
4',4'''-(2,2-二苯基乙烯-1,1-二基)双([1,1'-联苯]-4-甲醛)
|
2131097-89-5
|
C40H28O2
|
|
Teneligliptin Impurity 11
|
替格列汀杂质11
|
2131105-24-1
|
C25H35N5O4
|
|
9,9'-Spirobi[9H-fluoren]-3-amine, N-[1,1'-biphenyl]-2-yl-
|
9,9'-Spirobi[9H-fluoren]-3-amine, N-[1,1'-biphenyl]-2-yl-
|
2131158-87-5
|
C37H25N
|
|
Stannane, 1,1′-[4,8-bis[5-(2-butyloctyl)-4-fluoro-2-thienyl]benzo[1,2-b:4,5-b′]dithiophene-2,6-diyl]bis[1,1,1-trimethyl-
|
(4,8-双(5-(2-丁基辛基)-4-氟噻吩-2-基)苯并[1,2-B:4,5-B']二噻吩-2,6-二基)双三甲基锡
|
2131164-64-0
|
C48H72F2S4Sn2
|
|
VU0661013
|
VU0661013
|
2131184-57-9
|
C39H39Cl2N5O4
|
|
Methyl 5-bromo-3,4-dihydro-2H-benzo[b][1,4]oxazine-7-carboxylate
|
5-溴-3,4-二氢-2H-苯并[B][1,4]噁嗪-7-羧酸甲酯
|
2131191-71-2
|
C10H10BrNO3
|
|
YW1128
|
5-METHYL-1-(2-METHYLPHENYL)-N-2-QUINOLINYL-1H-1;2;3-TRIAZOLE-4-CARBOXAMIDE
|
2131223-64-6
|
C20H17N5O
|
|
YW1159
|
COMPOUND 3D;1-(2-FLUOROPHENYL)-5-METHYL-N-2-QUINOLINYL-1H-1;2;3-TRIAZOLE-4-CARBOXAMIDE
|
2131223-69-1
|
C19H14FN5O
|
|
Methanimidamide, N'-(4-amino-2-cyanophenyl)-N,N-dimethyl-, (1E)-
|
(E)-N'-(4-氨基-2-氰基苯基)-N,N-二甲基甲脒
|
2131230-48-1
|
C10H12N4
|
|
3-methyl-4-(1,2,4-triazolo[4,3-c]pyrimidin-7-yloxy)-Benzenamine
|
SHBF
|
2131230-56-1
|
C12H11N5O
|
|
Physaminimin N
|
Physaminimin N
|
2131235-87-3
|
C28H36O8
|
|
L-Serine, N-((1,1-dimethylethoxy)carbonyl)-O-(trifluoromethy
|
L-Serine, N-((1,1-dimethylethoxy)carbonyl)-O-(trifluoromethy
|
2131238-29-2
|
C9H14F3NO5
|
|
6-Chloro-3-iodo-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one
|
6-氯-3-碘-1,5-二氢吡唑并[3,4-D]嘧啶-4-酮
|
2131742-03-3
|
C5H2ClIN4O
|
|
Pyridine, 4,4'-[[(1E)-1,2-diphenyl-1,2-ethenediyl]di-4,1-phenylene]bis-
|
(E)-1,2-二苯基-1,2-双(4-(吡啶-4-基)苯基)乙烯
|
2131742-57-7
|
C36H26N2
|
|
N1-Ethoxymethyl pseudouridine
|
N1-乙氧基甲基假尿苷
|
2131744-33-5
|
C11H16N2O7
|
|
12-O-Methylinophyllum A
|
12-O-Methylinophyllum A
|
2131757-10-1
|
C26H26O5
|
|
GSK-656
|
化合物 T11497
|
2131798-13-3
|
C10H14BCl2NO4
|
|
WYC-209
|
4,5-二(羟甲基)-2-苯基-1H-咪唑
|
2131803-90-0
|
C20H20N2O3S
|
|
WYC-210
|
2-((4,4-二甲基-1-氧化硫代苯并二氢吡喃-6-基)乙炔基)嘧啶-5-羧酸
|
2131803-93-3
|
C18H16N2O3S
|
|
N-[(1S)-(1-Ferrocenyl)-2-(diphenylphosphino)ethyl)]-3,5-bis(trifluoromethyl)-benzamide
|
N-[(1S)-(1-Ferrocenyl)-2-(diphenylphosphino)ethyl)]-3,5-bis(trifluoromethyl)-benzamide
|
2131816-17-4
|
C33H26F6FeNOP
|
|
5H-Dibenzo[b,d]silole, 5-(3-bromophenyl)-5-phenyl-
|
5-(3-溴苯基)-5-苯基-5H-二苯并[B,D]硅烷
|
2131835-40-8
|
C24H17BrSi
|
|
(2-fluoro-6-(pyrrolidin-1-yl)pyridin-3-yl)boronic acid
|
2-氟-6-(吡咯烷-1-基)吡啶-3-硼酸
|
2132382-87-5
|
C9H12BFN2O2
|
|
Mumeose K
|
Mumeose K
|
2132384-01-9
|
C25H32O15
|
|
(S)-(4-Bromophenyl)(2-(4-chlorophenyl)piperazin-1-yl)methanone hydrochloride
|
(S)-(4-溴苯基)(2-(4-氯苯基)哌嗪-1-基)甲酮盐酸盐
|
2132392-81-3
|
C17H17BrCl2N2O
|
|
CD73-IN-1
|
2132396-40-6
|
2132396-40-6
|
C18H17N3O4S
|
|
AZD-3458
|
AZD-3458
|
2132961-46-5
|
C20H23N3O4S2
|
|
EPhos Pd G4
|
EPhos Pd G4
|
2132978-44-8
|
C50H70NO4PPdS
|
|
2-?Propanol, 1-?chloro-?3-?(1H-?indol-?4-?yloxy)?-?, (2R)?-
|
2132997-35-2
|
2132997-35-2
|
C11H12ClNO2
|
|
5-bromo-4-nitro-1H-indazole
|
5-溴-4-硝基-1H-吲唑
|
2133005-85-1
|
C7H4BrN3O2
|
|
GLP-26
|
GLP-26
|
2133017-36-2
|
C19H17F2N3O3
|
|
Apixaban Impurity 25
|
Apixaban Impurity 25
|
2133292-60-9
|
C26H27ClN4O5
|
|
Foliglurax hydrochloride
|
FOLIGLURAX MONOHYDROCHLORIDE
|
2133294-96-7
|
C23H24ClN3O3S
|
|
4,7-Diazaspiro[2.5]octane-4-carboxylic acid, 7-(2-hydroxy-4-oxo-4H-pyrido[1,2-a]pyrimidin-7-yl)-, 1,1-dimethylethyl ester
|
4,7-二氮杂螺[2.5]辛烷-4-羧酸,7-(2-羟基-4-氧基- 4H -吡啶[1,2-A]嘧啶-7-基)- 1,1-二甲基乙基酯
|
2133298-72-1
|
C19H24N4O4
|
|
4,7-Diazaspiro[2.5]octane-4-carboxylic acid, 7-[2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-7-yl]-, 1,1-dimethylethyl ester
|
利司扑兰中间体
|
2133298-74-3
|
C27H31N7O3
|
|
PROTAC BRD4 Degrader-1
|
化合物 PROTAC BRD4 Degrader-1
|
2133360-00-4
|
C40H37N9O8
|
|
Pomalidomide-PEG1-azide
|
泊马度胺-PEG-1叠氮化物
|
2133360-04-8
|
C17H16N6O6
|
|
Vildagliptin dihydrate
|
维格列汀二水合物
|
2133364-01-7
|
C17H27N3O3
|
|
6-Bromo-benzoic-2,3,4,5-d4 Acid
|
6-Bromo-benzoic-2,3,4,5-d4 Acid
|
2133385-73-4
|
C7H5BrO2
|
|
Dapagliflozin Impurity 19
|
Dapagliflozin Impurity 19
|
2133407-73-3
|
C18H23ClOSi
|
|
Dapagliflozin Impurity D
|
达格列净杂质D
|
2133407-75-5
|
C21H25ClO6
|
|
1H-Pyrazole-3-carboxamide, 5-ethyl-4-methyl-N-[4-(2S)-2-morpholinylphenyl]-
|
化合物RALMITARONT
|
2133417-13-5
|
C17H22N4O2
|
|
1-[3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4-methylpiperazine
|
|
2133421-20-0
|
C17H26BFN2O2
|
|
Pyrano[4,3-c]pyrazole-3-carboxylic acid, 1,4,6,7-tetrahydro-, methyl ester
|
Pyrano[4,3-c]pyrazole-3-carboxylic acid, 1,4,6,7-tetrahydro-, methyl ester
|
2133444-68-3
|
C8H10N2O3
|
|
(3S,5S,6S)-Bupropion Impurity
|
(3S,5S,6S)-安非他酮杂质
|
2133460-42-9
|
C12H14ClNO3S
|
|
(3S,5R,6R)-Bupropion Impurity
|
(3S,5R,6R)-安非他酮杂质
|
2133460-43-0
|
C12H14ClNO3S
|
|
(Difluoromethyl)bis(2,5-dimethylphenyl)sulfonium Tetrafluoroborate
|
(二氟甲基)双(2,5-二甲基苯基)锍四氟硼酸盐
|
2133476-51-2
|
C17H19BF6S
|
|
HSP27 inhibitor J2
|
HSP27 inhibitor J2
|
2133499-85-9
|
C13H12O4S
|
|
1-N-Methyl Lenalidomide
|
1-N-METHYL LENALIDOMIDE
|
2133816-23-4
|
C14H15N3O3
|
|
Oxazole, 2,2'-cyclopentylidenebis[4,5-dihydro-4,5-diphenyl-, (4R,4'R,5S,5'S)-
|
Oxazole, 2,2'-cyclopentylidenebis[4,5-dihydro-4,5-diphenyl-, (4R,4'R,5S,5'S)-
|
2133827-34-4
|
C35H32N2O2
|
|
(S)-2-Amino-3-(4-(carboxymethyl)phenyl)propanoic acid hydrochloride
|
4-(羧甲基)-L-苯丙氨酸盐酸盐
|
2133832-82-1
|
C11H14ClNO4
|
|
R-IMPP
|
R-IMPP
|
2133832-83-2
|
C24H27N3O2
|
|
INDEX NAME NOT YET ASSIGNED
|
DMT-DP-CE-PHOSPHORAMIDITE
|
2133842-85-8
|
C51H56N5O9P
|
|
HS-10296 hydrochloride
|
HS-10296 HYDROCHLORIDE
|
2134096-03-8
|
C30H36ClN7O2
|
|
2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1)
|
阿美替尼甲磺酸盐
|
2134096-06-1
|
C31H39N7O5S
|
|
Amorolfine Impurity 5(Amorolfine EP Impurity E)
|
Amorolfine Impurity 5(Amorolfine EP Impurity E)
|
2134097-34-8
|
C21H35NO
|
|
Ibrutinib Impurity 17
|
依鲁替尼杂质17
|
2134109-10-5
|
C16H18N6O
|
|
rac 1-Lauroyl-2-linoleoyl-3-chloropropanediol
|
rac 1-Lauroyl-2-linoleoyl-3-chloropropanediol
|
2134114-60-4
|
C33H59ClO4
|
|
triazine derivatives for oled
|
triazine derivatives for oled
|
2134165-04-9
|
C15H9Cl2N3
|
|
Formamide, N-[3-[[2-cyano-4-methyl-5-[[4-[[2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]-1H-indol-1-yl]methyl]bicyclo[1.1.1]pent-1-yl]-
|
2134169-43-8
|
2134169-43-8
|
C32 H35 F3 N8 O S
|
|
4,7,10,13,16,19,22-Heptaoxapentacosanedioic acid, 1-(1,1-dimethylethyl) ester
|
4,7,10,13,16,19,22-Heptaoxapentacosanedioic acid, 1-(1,1-dimethylethyl) ester
|
2134235-86-0
|
C22H42O11
|
|
SR17018
|
SR17018
|
2134602-45-0
|
C19H18Cl3N3O
|
|
Quinazoline, 7-bromo-2,4-dichloro-8-fluoro-6-(trifluoromethyl)-
|
7-溴-2,4-二氯-8-氟-6-(三氟甲基)喹唑啉
|
2134618-53-2
|
C9HBrCl2F4N2
|
|
Benzoic acid, 2-amino-4-bromo-3-fluoro-5-(trifluoromethyl)-
|
2-氨基-4-溴-3-氟-5-(三氟甲基)苯甲酸
|
2134633-62-6
|
C8H4BrF4NO2
|
|
Posaconazole Impurity 60
|
Posaconazole Impurity 60
|
2134652-05-2
|
C14H14F2O4
|
|
1H-Indole-2-carbonitrile, 4-methyl-5-[[4-[[2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]-1-[(2S)-2-[4-(methylsulfonyl)-1-piperazinyl]propyl]-
|
ZIFTOMENIB
|
2134675-36-6
|
C33H42F3N9O2S2
|
|
(R)-tert-butyl 3-oxo-2-phenylpiperazine-1-carboxylate
|
(R)-tert-butyl 3-oxo-2-phenylpiperazine-1-carboxylate
|
2135284-21-6
|
C15H20N2O3
|
|
β-Aspartic Acid-δ-Ornithine Dimer
|
(Β-门冬氨酸)-(Δ-鸟氨酸)
|
2135301-50-5
|
C9H17N3O5
|